top of page
News, Events and Updates
Search
Anavex Life Sciences Novel Sigma-1 / Sigma-2 Ligand Shows Encouraging Results as an Analgesic
Nov 14, 2016
Safety and Efficacy 31 Week Data of Anavex 2-73 in a Phase 2a Study in Mild-to-Moderate Alzheimer's
Nov 11, 2016
Investigating the Potential Neurorestorative Effects of a Clinical Sigma-1 Receptor Agonist
Nov 11, 2016
Global Mizuho Investor Conference (MIC)
Nov 11, 2016
Anavex Life Sciences Novel Sigma-1 / Sigma-2 Ligand Shows Encouraging Results as an Analgesic
Nov 11, 2016
Anavex Life Sciences and Ariana Pharma Collaborate to Accelerate Timelines and Improve Efficiency
Oct 4, 2016
Anavex Compound to be Tested in Biogen Neurological Protection Model
Sep 27, 2016
Anavex Life Sciences' Drug Shows Efficacy to Support Potential Disease Modification in Parkinson's
Sep 21, 2016
Anavex to Present at Ladenburg Thalmann 2016 Healthcare Conference
Sep 19, 2016
Ladenburg Thalmann 2016 Healthcare Conference
Sep 19, 2016
Mizuho Therapeutics Conference
Sep 13, 2016
27
28
29
30
31
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
